灵麦医药聚焦
肾病及肾病相关并发症
肾透析全球及中国市场分析
肾病市场的全球及中国治疗领先企业
全球创新治疗一览
Renal disease and related complications
Global and China renal dialysis market analysis
Global and Chinese therapeutic leaders in the renal disease market
Global innovative treatment assets list
活动详情
日期: 2019年12月04日周三 4:00 PM - 5:00PM
地点: Webex
演讲: 曹玲玲,CEO & 灵麦医药创始人; 王海盛,医学顾问
报名：021-5386 3003
RSVP：本次讲座免费(优先灵麦医药现有VIP客户) 请于2019年12月3日前注册
DATE: Wednesday December 4, 2019 4:00 PM - 5:00 PM
VENUE: Webex
PRESENTERS：Lingling Cao, CEO & Founder ，Dr. Hank Wang, Medical advisor
REGISTER ：+86 21 5386 3003
RSVP：This is a FREE event VIP tickets priority for Lingmed current clients. Please RSVP by December 3, 2019
活动日程
16 : 00-16 : 10 灵佰服务及项目简介 -曹玲玲 主讲
16 : 10-16 : 45 肾病专题市场潜力和全球新药进展探讨 -王海盛博士 主讲
16 : 45-16 : 55 提问和讨论
16 : 55-17 : 00 总结及反馈
16 : 00-16 : 10 Linkedbio services & projects introductions - by LingLing Cao
16 : 10-16 : 45 Renal Disease Market Potential and Global Market Trend Discussion - by Dr. Hank Wan
16 : 45-16 : 55 Panel discussions
16 : 55-17 : 00 Q&A
出席嘉宾
曹玲玲 CEO & 创始人
曹女士毕业于上海第二医科大学现交通大学医学院的临床医学系。并在欧洲荷兰马斯特里斯特大学取得国际商务的硕士学位。她曾任职德国麦肯锡顾问多年，专注于医药行业。她也曾在几家大型医药外企公司任职，如葛兰素史克，拜耳等。在过去几年中，曹女士曾在礼来制药担任新药业务拓展部的高级经理及集博公司的商务总监职位
Lingling Cao CEO & Founder
Lingling has more than a decade of experience in the healthcare industry, especially in deal-making. She founded Lingmed, which aims to support BD professionals to make better decisions with intelligence databases and EU-China cross-border deals. Prior to her venture at Lingmed, she was a senior BD manager for Eli Lilly in Shanghai and a consultant for McKinsey in Germany
王海盛 医学顾问
王博士在北京大学药物化学取得博士学位，并先后在密苏里大学圣路易斯分校及奥本大学从事过博士后研究工作。王海盛拥有10年以上的医药行业的从业经验，目前兼任美国药学科学家协会中国讨论组（AAPSCDG）主席；北京大学药学院兼职教授、专业硕士导师；中国医药生物技术协会(CMBA)生物医学信息技术分会委员；王博士是灵麦团队引进创新药品方面的专业顾
Dr. Hank Wang Medical advisor
Dr Wang holds a PhD degree on Medicinal Chemistry from Peking University, has a Postdoc experience in University of Missouri-Saint Louis, and worked as a Postdoc Fellow in Auburn University. Hank Wang has more than 10 years’ experience in pharmaceuticals industry. Hank has worked as Vice President and President of R&D at Beijing Haiyan Pharmaceutical Co., Ltd. - Yangtze River Pharmaceutical Group. Dr Wang advises Lingmed on innovative assets evaluation for China market
请点击文末“阅读原文” 马上注册吧或联系我们info@lingmed.net
灵麦医药是以下两家情报数据库在中国的独家合作伙伴：
Biotechgate/博谷 - 全球创新药和器械产品收购和引进数据库
EvaluatePharma/预估医药 - 全球医药研发、销售、市场预估等竞争情报数据库
点击下方“阅读原文”马上注册吧